Literature DB >> 25654505

The prevalence of depression in Alzheimer's disease: a systematic review and meta-analysis.

Song Chi, Chong Wang, Teng Jiang, Xi-Chen Zhu, Jin-Tai Yu, Lan Tan1.   

Abstract

Prevalence estimates of depression in AD vary greatly across studies, and a reliable result is crucial for further interventions. A systematic review and meta-analysis was conducted to identify the prevalence of depression in AD patients. We searched PubMed and Embase, followed by data extraction, quality assessment, prevalence estimates and subgroup analyses. A total of 63 studies were included in the review. The prevalences of depression were 12.7% (CI, 8.8-17.8) and 42% (CI, 38-45) according to the DSM criteria for major depression and the specific criteria for dementia respectively. Subgroup analyses stratified by case identification showed that the prevalences of population-based stud ies were 5% (CI: 2-15) and 35% (CI: 29-41) according to the DSM criteria and the specific criteria respectively, while those of single source were 17% (CI: 11-25) and 43% (CI: 37-49). Subgroup analyses stratified by MMSE score revealed that the prevalences of severe AD were 8% (CI: 5-15) and 48% (CI: 41-54) according to the DSM criteria and the specific criteria respectively, while those of mild AD were 14% (CI: 8-24) and 40% (CI: 32- 47). In conclusion, the prevalence of depression according to the DSM criteria was lower than that of the specific criteria. Prevalence estimates conducted in population-based studies were lower compared with those in single-source studies irrespective of the screening tools. Patients with severe AD tended to have higher prevalence of depression according to the specific criteria, while the trend was opposite according to the DSM criteria. Thus, different settings and diagnostic approaches should be taken into account before estimates of depression and further interventions.

Entities:  

Mesh:

Year:  2015        PMID: 25654505     DOI: 10.2174/1567205012666150204124310

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  30 in total

Review 1.  Therapeutic Potential of Genipin in Central Neurodegenerative Diseases.

Authors:  Yanwei Li; Lin Li; Christian Hölscher
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

Review 2.  Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.

Authors:  Ramon Cacabelos
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 3.  A practical approach to detection and treatment of depression in Parkinson disease and dementia.

Authors:  Zahra Goodarzi; Zahinoor Ismail
Journal:  Neurol Clin Pract       Date:  2017-04

4.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

5.  Neuropsychiatric Effects on Decision-Making in Early Alzheimer Disease.

Authors:  Oleg Yerstein; Andrew R Carr; Elvira Jimenez; Mario F Mendez
Journal:  J Geriatr Psychiatry Neurol       Date:  2020-03       Impact factor: 2.680

6.  Abnormal baseline brain activity in Alzheimer's disease patients with depression: a resting-state functional magnetic resonance imaging study.

Authors:  Xiaozheng Liu; Zhongwei Guo; Yanping Ding; Jiapeng Li; Gang Wang; Hongtao Hou; Xingli Chen; Enyan Yu
Journal:  Neuroradiology       Date:  2017-06-03       Impact factor: 2.804

Review 7.  Impact of Antidepressant Use on the Trajectory of Alzheimer's Disease: Evidence, Mechanisms, and Therapeutic Implications.

Authors:  Rita Khoury; George T Grossberg
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

8.  Low Arousal Positive Emotional Stimuli Attenuate Aberrant Working Memory Processing in Persons with Mild Cognitive Impairment.

Authors:  Lucas S Broster; Shonna L Jenkins; Sarah D Holmes; Gregory A Jicha; Yang Jiang
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 9.  Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression.

Authors:  Rita Businaro; David Vauzour; Jerome Sarris; Gerald Münch; Erika Gyengesi; Laura Brogelli; Pedro Zuzarte
Journal:  Front Nutr       Date:  2021-05-14

10.  Emotional Comparison Between Semantic Dementia and Alzheimer's Disease.

Authors:  Ping Wang; Qianhua Zhao; Yan Zhou; Zhen Hong; Qihao Guo; Jianren Liu
Journal:  Front Psychiatry       Date:  2021-05-13       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.